PY2189412A - Compuestos y composiciones para el tratamiento de la criptosporidiosis - Google Patents

Compuestos y composiciones para el tratamiento de la criptosporidiosis

Info

Publication number
PY2189412A
PY2189412A PY202102189412A PY2189412A PY2189412A PY 2189412 A PY2189412 A PY 2189412A PY 202102189412 A PY202102189412 A PY 202102189412A PY 2189412 A PY2189412 A PY 2189412A PY 2189412 A PY2189412 A PY 2189412A
Authority
PY
Paraguay
Prior art keywords
compounds
cryptosporidiosis
treatment
compositions
eradication
Prior art date
Application number
PY202102189412A
Other languages
English (en)
Spanish (es)
Inventor
Peichao Lu
Michael Turner
Joseph Michael Young
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PY2189412A publication Critical patent/PY2189412A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PY202102189412A 2020-10-14 2021-10-12 Compuestos y composiciones para el tratamiento de la criptosporidiosis PY2189412A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063091866P 2020-10-14 2020-10-14

Publications (1)

Publication Number Publication Date
PY2189412A true PY2189412A (es) 2022-05-17

Family

ID=78302850

Family Applications (1)

Application Number Title Priority Date Filing Date
PY202102189412A PY2189412A (es) 2020-10-14 2021-10-12 Compuestos y composiciones para el tratamiento de la criptosporidiosis

Country Status (12)

Country Link
US (1) US12018024B2 (https=)
EP (1) EP4229055B1 (https=)
JP (1) JP7791184B2 (https=)
CN (1) CN116368137A (https=)
AR (1) AR123766A1 (https=)
AU (1) AU2021362803A1 (https=)
CA (1) CA3197199A1 (https=)
MX (1) MX2023004435A (https=)
PY (1) PY2189412A (https=)
TW (1) TW202229277A (https=)
UY (1) UY39466A (https=)
WO (1) WO2022079616A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR132352A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados de imidazo[1,2-a]pirazina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2925757T (lt) 2012-11-19 2017-12-27 Novartis Ag Junginiai ir kompozicijos, skirti parazitinių ligų gydymui
CN108495853A (zh) * 2016-01-21 2018-09-04 诺华股份有限公司 用于治疗隐孢子虫病的化合物和组合物
GB201700692D0 (en) 2017-01-16 2017-03-01 Salvensis Novel compounds and their use in the treatment of schistosomiasis

Also Published As

Publication number Publication date
AR123766A1 (es) 2023-01-11
MX2023004435A (es) 2023-05-08
UY39466A (es) 2022-05-31
TW202229277A (zh) 2022-08-01
CN116368137A (zh) 2023-06-30
WO2022079616A1 (en) 2022-04-21
US20220112189A1 (en) 2022-04-14
US12018024B2 (en) 2024-06-25
CA3197199A1 (en) 2022-04-21
JP2023545452A (ja) 2023-10-30
EP4229055A1 (en) 2023-08-23
EP4229055B1 (en) 2026-03-04
JP7791184B2 (ja) 2025-12-23
AU2021362803A1 (en) 2023-06-01

Similar Documents

Publication Publication Date Title
CO2022010460A2 (es) Compuestos tricíclicos sustituidos
CR20220312A (es) Compuestos tricíclicos sustituidos
EA202092169A1 (ru) ПРИМЕНЕНИЕ ЗАМЕЩЕННЫХ АМИНОПРОПИОНАТНЫХ СОЕДИНЕНИЙ В ЛЕЧЕНИИ ИНФЕКЦИИ SARS-CoV-2
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
UY35400A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
MX2022007171A (es) Compuestos cíclicos y métodos de uso de estos.
UY39625A (es) Derivados tricíclicos útiles como inhibidores de parp7
CO2021014210A2 (es) Compuestos de pirrol
AR133266A1 (es) Macrociclos para el tratamiento de enfermedades autoinmunitarias
UY39181A (es) COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE HIF2a Y SUS MÉTODOS DE USO
CO2019004004A2 (es) Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico
CO2025003099A2 (es) Compuestos para el tratamiento del cáncer
AR128109A1 (es) Spiros y análogos relacionados para inhibir yap / taz-tead
JOP20250214A1 (ar) مشتقات هيدروكينازولين لعلاج مرض أو اضطراب
CO2022008616A2 (es) Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma
MX2022011240A (es) Azálidos de urea inmunomoduladores.
PY2189412A (es) Compuestos y composiciones para el tratamiento de la criptosporidiosis
AR128100A1 (es) Compuestos para el tratamiento de la pérdida del cabello
CO2022006942A2 (es) Compuestos de 1,8-naftiridin-2-ona para el tratamiento de una enfermedad autoinmunitaria
CO2024002712A2 (es) Azálidos inmunomoduladores
JOP20240119A1 (ar) مشتقات نافثيريدينون لمعالجة مرض أو اضطراب
MX2019003585A (es) Derivados de tetrahidropiridina y su uso como agentes antibacterianos.
MX2022015532A (es) Inhibidores selectivos de hdac6 y usos de los mismos.
AR131358A1 (es) Derivados de imidazotriazina como moduladores de il-17
AR131945A1 (es) Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno